MUC5B and idiopathic pulmonary fibrosis: Ectopic expression of MUC5B in terminal and respiratory bronchiolar airways in patients with IPF, especially in those with the MUC5B promoter variant (11, 66, 75), is thought to disrupt lung homeostasis and promote fibrotic remodeling in these vulnerable distal regions of the lung.